HPS Pharmacies wish to give notice that Indivior is experiencing a supply interruption for Temgesic® as follows:

Temgesic® Sublingual Tablet
Buprenorphine 200mcg
ARTG 34091 

Temgesic® Ampoule
Buprenorphine 300mcg/mL
ARTG 15394

Normal supplies of Temgesic® ampoules are expected to return in early February 2022. Normal supplies of Temgesic® sublingual tablets are expected to return in early March 2022. HPS Pharmacies has sourced an internationally registered alternative of buprenorphine ampoules which may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Indivior on (02) 9025 0200 or your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates